Dernières nouvelles pour Intuitive Surgical (NASDAQ:ISRG) Stock

INTUITIVE SURGICAL INC

Intuitive Surgical

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 15 years by 6.63% on an annualized basis producing an average annual return of 19.01%. Currently, Intuitive Surgical has a market capitalization of $180.36 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 15 years ago, it would be worth $1,365.72 today based on a price of $503.20 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753369231_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

ISRG

$100 Invested In Intuitive Surgical 15 Years Ago Would Be Worth This Much Today

UBS analyst Danielle Antalffy maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Neutral and raises the price target from $547 to $585.

Price Target

Analyst Ratings

UBS Maintains Neutral on Intuitive Surgical, Raises Price Target to $585

A wave of U.S. trade deals with key allies over the past 24 hours reignited Wall Street's rally and boosted investor risk <a href="https://www.benzinga.com/markets">appetite across global markets.</a>
President Donald Trump announced agreements with the Philippines, Indonesia and—most significantly—Japan, while the <a href="https://www.ft.com/content/460b7784-88d7-4324-9e4d-dc9692d15e72">Financial Times</a> reported that a U.S.-EU trade deal is imminent, expected to mirror the Tokyo framework.
The U.S.-Japan pact raises the baseline tariff on Japanese goods to 15% from 10%, sidestepping the previously threatened 25% level. Tariffs on Japanese autos have been cut from 25% to 15%. In return, Japan committed to investing $550 billion in the U.S. and easing access to American agricultural and industrial goods.
Markets cheered the progress. The S&amp;P 500 rose 0.5% to a new record high of 6,350, while the Dow Jones Industrial Average surged nearly 1%, or 450 points, nearing its own record. Small-cap stocks led the charge, with the Russell 2000 also jumping 1.0% to its highest level since February.
International equities soared even more. The iShares MSCI Japan Index Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWJ#NYSE">EWJ</a>) rallied 4.9% to an all-time high, the SPDR DJ Euro STOXX 50 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FEZ#NYSE">FEZ</a>) climbed nearly 2%, and the iShares MSCI Mexico ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWW#NYSE">EWW</a>) gained 2.1%.
As optimism over global trade thawed investor caution, demand for safe-haven assets dropped. Gold slid 1.4% to $3,383 per ounce, while silver dipped 0.3%. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell 2% to $117,760. 
Next up: a major earnings test. Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), ServiceNow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) and IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) are all set to report results after Wednesday's close.
<h2 class="wp-block-heading">Wednesday&#8217;s Performance Of US Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>% Chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,272.31</td>
<td>1.0%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,892.90</td>
<td>0.9%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,340.17</td>
<td>0.5%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>23,077.71</td>
<td>0.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:40 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) rose 0.5% to $580.89.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.9% to $448.95.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;held steady at $561.44.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) soared 1.1% to $225.66.</li>
<li>The&nbsp;Industrials&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>) outperformed, up 1.8%; the&nbsp;Utilities&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) lagged, down 0.8%.</li>
</ul>
<h3 class="wp-block-heading">Wednesday&#8217;s Stocks Movers</h3>
<ul class="wp-block-list">
<li>GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) soared 13% after beating the Street&#8217;s estimates last quarter.</li>
</ul>
Other stocks reacting to earnings reports included:
<ul class="wp-block-list">
<li>Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) down 3.54%</li>
<li>Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) down 11.80%</li>
<li>Boston Scientific Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) up 3.94%</li>
<li>NextEra Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) down 6.62%</li>
<li>Amphenol Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) up 3.15%</li>
<li>CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) up 1.32%</li>
<li>Moody's Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) up 2.14%</li>
<li>Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) up 2.30%</li>
<li>General Dynamics Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) up 6.47%</li>
<li>Fiserv Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FI#NASDAQ">FI</a>) down 16.10%</li>
<li>Infosys Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>) up 1.66%</li>
<li>Freeport-McMoRan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) down 1.84%</li>
<li>Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) down 2.04%</li>
<li>TE Connectivity plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>) up 10.30%</li>
<li>CoStar Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) up 6.34%</li>
<li>Otis Worldwide Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTIS#NYSE">OTIS</a>) down 10.32%</li>
<li>Teledyne Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) down 3.76%</li>
<li>Lennox International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) up 8.84%</li>
<li>Northern Trust Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>) down 3.53%</li>
<li>Rogers Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCI#NYSE">RCI</a>) up 0.29%</li>
<li>East West Bancorp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) down 2.16%</li>
<li>Mr. Cooper Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NASDAQ">COOP</a>) up 0.90%</li>
<li>Hasbro Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>) down 0.73%</li>
<li>Lamb Weston Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) up 16.08%</li>
</ul>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46557704/trump-america-first-agenda-ai-industrial-stocks-defense-sector">Trump&#8217;s Sledgehammer Policies Have Ignited Wall Street&#8217;s Hottest Trade—And It&#8217;s Not AI </a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Government

Large Cap

Macro Economic Events

Regulations

Sector ETFs

Broad U.S. Equity ETFs

Emerging Market ETFs

Commodities

Economics

Tech

ETFs

$BTC

COOP

CSGP

SPDR Dow Jones Industrial Average ETF Trust

EWBC

GOOGL

INFY

NTRS

OTIS

TSLA

Stocks Jump On Trump's Trade Deal Deluge Ahead Of Big Tech Earnings: What's Moving Markets Wednesday?

Piper Sandler analyst Adam Maeder reiterates Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Overweight and raises the price target from $575 to $595.

Reiteration

Piper Sandler Reiterates Overweight on Intuitive Surgical, Raises Price Target to $595

WIIM

Intuitive Surgical shares are trading lower following Q2 reported financial results.

Truist Securities analyst Richard Newitter maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and raises the price target from $590 to $600.

Truist Securities Maintains Buy on Intuitive Surgical, Raises Price Target to $600

RBC Capital analyst Shagun Singh maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Outperform and raises the price target from $605 to $615.

RBC Capital Maintains Outperform on Intuitive Surgical, Raises Price Target to $615

Wells Fargo analyst Larry Biegelsen maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Overweight and raises the price target from $559 to $599.

Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $599

BTIG analyst Ryan Zimmerman maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and raises the price target from $566 to $571.

BTIG Maintains Buy on Intuitive Surgical, Raises Price Target to $571

Intuitive Surgical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) reported financial results for the second quarter after the market close on Tuesday. Here&#8217;s a look at hey metrics <a href="https://www.benzinga.com/pressreleases/25/07/g46558462/intuitive-announces-second-quarter-earnings">from the quarter</a>.
Q2 Earnings: Intuitive Surgical reported second-quarter revenue of $2.44 billion, beating analyst&nbsp;<a href="http://benzinga.com/quote/isrg/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $2.35 billion, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The robotic-assisted surgery company reported second-quarter adjusted earnings of $2.19 per share, beating analyst estimates of $1.93 per share.
Total revenue was up 21% year-over-year as Worldwide da Vinci procedures increased approximately 17%. The company said it&nbsp;placed 395 da Vinci surgical systems in the quarter, versus 341 in the prior year's quarter. Intuitive Surgical's da Vinci surgical system installed base grew to 10,488 systems as of June 30, up 14% year-over-year.
Intuitive Surgical ended the quarter with $9.53 billion in cash, cash equivalents and investments, up $431 million from the first quarter.
&#8220;We&#8217;re pleased with our solid performance this quarter, highlighted by continued customer adoption of our newer and existing platforms, including da Vinci 5,&#8221; stated Dave Rosa, CEO of Intuitive Surgical.
&#8220;We are committed to advancing care, and helping our customers provide better patient outcomes, better patient and care team experiences, broadening access to care and decreasing the total cost of care.&#8221;
Outlook: Intuitive Surgical expects full-year 2025 worldwide da Vinci procedures to increase approximately&nbsp;15.5%&nbsp;to&nbsp;17%. The company expects gross profit margin to be between&nbsp;66%&nbsp;and&nbsp;67%&nbsp;of revenue in 2025, which includes an estimated 1% impact from tariffs.
Company executives are set to further discuss the quarter on a call with investors and analysts at 4:30 p.m. ET.
ISRG Price Action: <a href="http://benzinga.com/quote/isrg" target="_blank" rel="noreferrer noopener">Intuitive Surgical shares</a> were down 4.11% in after-hours, trading at $490 at the time of publication Tuesday, according to data from <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46552653/wall-street-today-markets-tuesday-lockheed-general-motors-gold-price-dollar">Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What&#8217;s Moving Markets Tuesday?</a></li>
</ul>
Photo: Shutterstock.

Earnings

Guidance

Health Care

After-Hours Center

Movers

Intuitive Surgical Beats Q2 Earnings Estimates As Revenue Jumps 21%, Shares Slide

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) reported quarterly earnings of $2.19 per share which beat the analyst consensus estimate of $1.93 by 13.77 percent. This is a 23.03 percent increase over earnings of $1.78 per share from the same period last year. The company reported quarterly sales of $2.440 billion which beat the analyst consensus estimate of $2.348 billion by 3.91 percent. This is a 21.39 percent increase over sales of $2.010 billion the same period last year.

Earnings Beats

Intuitive Surgical Q2 Adj. EPS $2.19 Beats $1.93 Estimate, Sales $2.440B Beat $2.348B Estimate

It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of a critical <a href="https://www.benzinga.com/topic/magnificent-seven">wave of tech earnings.</a>
By midday trading in New York, the S&amp;P 500 dipped 0.1% and the Nasdaq 100 slipped 0.5%, pulling back after hitting fresh all-time highs on Monday. The Russell 2000 outperformed, rising 0.6%.
Weak corporate results weighed on sentiment. Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) plunged 9.5% after missing revenue forecasts. Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) dropped more than 8% on a double miss, and General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) lost 5.5% after warning of a steeper-than-expected tariff hit in the second half of 2025.
Health care led sector gains, while tech stocks lagged, as attention turns to earnings from Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) which are slated to report earnings on Wednesday. 
On the macro front, Treasury Secretary Scott Bessent said the U.S. will meet with Chinese officials next week to continue trade negotiations. That raised hopes for an extension to the August 12 China tariff deadline.
In the bond market, the 10-year Treasury yield fell for a fifth straight session to 4.33%, its lowest level in over a week. Meanwhile, the U.S. dollar index dropped 0.4%, extending its slide for a third day.
Gold climbed 0.9% to $3,420 per ounce, the highest since June 16, as uncertainty surrounding the Federal Reserve's independence and Chair Jerome Powell's future fueled safe-haven demand.
In crypto, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rose 1.4% to $119,000, extending its rebound alongside broader market hedging flows.
Read also:<a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46549915/el-erian-powell-trump-resign-fed-independence-scott-bessent"> El-Erian Says Powell Should Resign—To Save The Fed Itself</a>
<h3 class="wp-block-heading">Tuesday&#8217;s Performance Of Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,243.42</td>
<td>0.6%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,378.27</td>
<td>0.1%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,300.18</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>23,073.22</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) eased 0.2% to $557.08.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) flattened at $443.63.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;eased 0.6% to $560.86.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 0.6% at $222.67.</li>
<li>The&nbsp;Health Care&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) outperformed, up 1.3%; the&nbsp;Technology&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) lagged, down 0.7%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h3>
Stocks reacting on earnings reports included: 
<ul class="wp-block-list">
<li>D.R. Horton Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>), up 14.5%</li>
<li>Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>), up 8.4%</li>
<li>PACCAR Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>), up 4.7%</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>), down 6.8%</li>
<li>RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>), down 2.5%</li>
<li>Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), down 1.0%</li>
<li>Danaher Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), down 0.3%</li>
<li>Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), down 7.2%</li>
<li>IQVIA Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) up 18%, </li>
<li>Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) up 1.5%</li>
<li>PulteGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) up 9.4%</li>
<li>KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) up 1.6%</li>
<li>Quest Diagnostics Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) up 6.3%</li>
<li>Halliburton Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) up 0.4%</li>
<li>Genuine Parts Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) up 5.5%</li>
<li>Tenet Healthcare Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) down 4.3%</li>
<li>Avery Dennison Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) up 0.3%</li>
<li>Invesco Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) up 4.1%</li>
<li>Mueller Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>) up 0.5%</li>
<li>Old National Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) down 1.2%</li>
<li>Valmont Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) up 5.1%</li>
<li>Badger Meter Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMI#NYSE">BMI</a>) down 13.8% </li>
<li>Medpace Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>), up 53.2%</li>
</ul>
Companies slated to report earnings after the close include Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>), CoStar Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>), EQT Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>), Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) and East West Bancorp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>). 
Read now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46543934/formula-1-liberty-fwonk-stock-goldman-sachs-forecasts">Formula 1 Is Wall Street&#8217;s New Money Machine—With Horsepower </a></li>
</ul>
Image: Shutterstock

Equities

ENPH

MEDP

MSCI

PCAR

Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What's Moving Markets Tuesday?

<h3>Companies Reporting Before The Bell</h3>
• PulteGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) is expected to report quarterly earnings at $2.97 per share on revenue of $4.40 billion. 
• RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) is expected to report quarterly earnings at $1.44 per share on revenue of $20.64 billion. 
• Hope Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOPE#NASDAQ">HOPE</a>) is likely to report quarterly earnings at $0.21 per share on revenue of $131.11 million. 
• General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) is likely to report quarterly earnings at $2.41 per share on revenue of $45.57 billion. 
• D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) is estimated to report quarterly earnings at $2.91 per share on revenue of $8.79 billion. 
• Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) is estimated to report quarterly earnings at $2.86 per share on revenue of $5.16 billion. 
• Northrop Grumman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) is likely to report quarterly earnings at $6.69 per share on revenue of $10.12 billion. 
• Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) is likely to report quarterly earnings at $6.54 per share on revenue of $18.57 billion. 
• Invesco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) is projected to report quarterly earnings at $0.39 per share on revenue of $1.10 billion. 
• Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) is estimated to report quarterly earnings at $1.71 per share on revenue of $4.03 billion. 
• Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) is projected to report quarterly earnings at $1.85 per share on revenue of $10.30 billion. 
• Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) is projected to report quarterly loss at $0.01 per share on revenue of $85.00 million. 
• PACCAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) is expected to report quarterly earnings at $1.34 per share on revenue of $6.95 billion. 
• MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) is projected to report quarterly earnings at $4.12 per share on revenue of $767.15 million. 
• Old National (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) is likely to report quarterly earnings at $0.51 per share on revenue of $622.93 million. 
• The Interpublic Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPG#NYSE">IPG</a>) is expected to report quarterly earnings at $0.56 per share on revenue of $2.16 billion. 
• Halliburton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) is expected to report quarterly earnings at $0.56 per share on revenue of $5.43 billion. 
• Avery Dennison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) is likely to report quarterly earnings at $2.41 per share on revenue of $2.23 billion. 
• MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $288.14 million. 
• Capital City Bank Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCBG#NASDAQ">CCBG</a>) is likely to report quarterly earnings at $0.80 per share on revenue of $62.25 million. 
• Valmont Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) is projected to report quarterly earnings at $4.76 per share on revenue of $1.03 billion. 
• Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) is projected to report quarterly earnings at $3.79 per share on revenue of $6.30 billion. 
• Pentair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) is likely to report quarterly earnings at $1.33 per share on revenue of $1.11 billion. 
• Peoples Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEBO#NASDAQ">PEBO</a>) is projected to report quarterly earnings at $0.77 per share on revenue of $113.08 million. 
• Mercantile Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBWM#NASDAQ">MBWM</a>) is projected to report quarterly earnings at $1.24 per share on revenue of $60.17 million. 
• Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) is likely to report quarterly earnings at $0.83 per share on revenue of $12.57 billion. 
• KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) is estimated to report quarterly earnings at $0.34 per share on revenue of $1.80 billion. 
• IQVIA Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) is expected to report quarterly earnings at $2.66 per share on revenue of $3.96 billion. 
• Genuine Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) is projected to report quarterly earnings at $2.07 per share on revenue of $6.11 billion. 
• Forestar Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOR#NYSE">FOR</a>) is expected to report quarterly earnings at $0.77 per share on revenue of $395.20 million. 
• First BanCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBP#NYSE">FBP</a>) is projected to report quarterly earnings at $0.46 per share on revenue of $251.62 million. 
• Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) is expected to report quarterly earnings at $1.92 per share on revenue of $1.51 billion. 
• Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) is expected to report quarterly earnings at $1.64 per share on revenue of $5.84 billion. 
• Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) is expected to report quarterly earnings at $2.57 per share on revenue of $2.72 billion. 
• Community Financial Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBU#NYSE">CBU</a>) is expected to report quarterly earnings at $1.02 per share on revenue of $202.48 million. 
• Badger Meter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMI#NYSE">BMI</a>) is projected to report quarterly earnings at $1.22 per share on revenue of $235.90 million. 
<h3>Companies Reporting After The Bell</h3>
• Orrstown Financial Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORRF#NASDAQ">ORRF</a>) is expected to report quarterly earnings at $0.98 per share on revenue of $51.98 million. 
• Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) is expected to report quarterly earnings at $1.93 per share on revenue of $2.35 billion. 
• Core Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNR#NYSE">CNR</a>) is expected to report quarterly earnings at $1.90 per share on revenue of $4.34 billion. 
• Capital One Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) is projected to report quarterly earnings at $3.56 per share on revenue of $12.51 billion. 
• Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) is estimated to report quarterly earnings at $0.62 per share on revenue of $358.02 million. 
• Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) is expected to report quarterly earnings at $1.13 per share on revenue of $263.49 million. 
• PennyMac Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFSI#NYSE">PFSI</a>) is projected to report quarterly earnings at $3.07 per share on revenue of $551.41 million. 
• Matador Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTDR#NYSE">MTDR</a>) is estimated to report quarterly earnings at $1.34 per share on revenue of $905.51 million. 
• Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) is estimated to report quarterly earnings at $0.65 per share on revenue of $714.71 million. 
• Northpointe Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPB#NYSE">NPB</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $57.61 million. 
• EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) is projected to report quarterly earnings at $0.43 per share on revenue of $1.78 billion. 
• Canadian National Railway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) is expected to report quarterly earnings at $1.37 per share on revenue of $3.16 billion. 
• Pegasystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $367.24 million. 
• PennyMac Mortgage IT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PMT#NYSE">PMT</a>) is projected to report quarterly earnings at $0.36 per share on revenue of $94.33 million. 
• Chubb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) is likely to report quarterly earnings at $5.92 per share on revenue of $13.45 billion. 
• East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) is likely to report quarterly earnings at $2.23 per share on revenue of $700.82 million. 
• CoStar Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $771.82 million. 
• Karooooo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) is projected to report quarterly earnings at $0.45 per share on revenue of $71.47 million. 
• SAP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) is likely to report quarterly earnings at $1.63 per share on revenue of $10.39 billion. 
• Weatherford International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) is likely to report quarterly earnings at $0.98 per share on revenue of $1.19 billion. 
• Vicor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VICR#NASDAQ">VICR</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $96.43 million. 
• Usana Health Sciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USNA#NYSE">USNA</a>) is likely to report quarterly earnings at $0.54 per share on revenue of $225.20 million. 
• Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) is estimated to report quarterly earnings at $1.32 per share on revenue of $4.31 billion. 
• Trustmark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMK#NASDAQ">TRMK</a>) is expected to report quarterly earnings at $0.86 per share on revenue of $200.74 million. 
• Renasant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) is projected to report quarterly earnings at $0.74 per share on revenue of $262.07 million. 
• National Bank Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBHC#NYSE">NBHC</a>) is expected to report quarterly earnings at $0.80 per share on revenue of $109.81 million. 
• KKR Real Est Finance Tr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KREF#NYSE">KREF</a>) is projected to report quarterly loss at $0.07 per share on revenue of $31.90 million. 
• Hanmi Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAFC#NASDAQ">HAFC</a>) is likely to report quarterly earnings at $0.61 per share on revenue of $65.58 million. 
• First Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRBA#NASDAQ">FRBA</a>) is expected to report quarterly earnings at $0.42 per share on revenue of $35.27 million. 
• Cathay General (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CATY#NASDAQ">CATY</a>) is likely to report quarterly earnings at $1.10 per share on revenue of $196.36 million. 
• Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) is expected to report quarterly earnings at $5.29 per share on revenue of $877.03 million. 
• First Busey (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BUSE#NASDAQ">BUSE</a>) is likely to report quarterly earnings at $0.62 per share on revenue of $193.20 million. 
• Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) is estimated to report quarterly earnings at $0.55 per share on revenue of $6.63 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BUSE

CALM

CATY

CCBG

FRBA

HAFC

HOPE

KARO

KREF

MANH

MBWM

MMYT

MTDR

NBHC

ORRF

PEBO

PEGA

PFSI

RNST

SPWR

TRMK

USNA

VICR

WFRD

Earnings Scheduled For July 22, 2025

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) will release its quarterly earnings report on Tuesday, 2025-07-22. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Intuitive Surgical to report an earnings per share (EPS) of $1.77.
Intuitive Surgical bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.09, leading to a 1.92% increase in the share price the following trading session.
Here's a look at Intuitive Surgical's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.72</td>
<td>1.79</td>
<td>1.63</td>
<td>1.54</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.81</td>
<td>2.21</td>
<td>1.84</td>
<td>1.78</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>-4.0%</td>
<td>10.0%</td>
<td>9.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753106523_0.png" alt="eps graph" />
<h3>Performance of Intuitive Surgical Shares</h3>
Shares of Intuitive Surgical were trading at $518.62 as of July 18. Over the last 52-week period, shares are up 13.64%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/ISRG/earnings">To track all earnings releases for Intuitive Surgical visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights Ahead: Intuitive Surgical's Quarterly Earnings

Intuitive Demonstrates Telesurgery Capabilities By Remotely Connecting Two Surgeons To Perform Transatlantic Demonstration At SRS Conference In Strasbourg, France

Investors with a lot of money to spend have taken a bearish stance on Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ISRG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 13 uncommon options trades for Intuitive Surgical.
This isn't normal.
The overall sentiment of these big-money traders is split between 30% bullish and 53%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $264,370, and 6 are calls, for a total amount of $503,844.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $380.0 to $550.0 for Intuitive Surgical during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale activity within a strike price range from $380.0 to $550.0 in the last 30 days. 
<h3>Intuitive Surgical Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752253237_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$156.7</td>
<td>$153.8</td>
<td>$153.8</td>
<td>$420.00</td>
<td>$230.7K</td>
<td align="right">4</td>
<td align="right">15</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$16.2</td>
<td>$15.6</td>
<td>$15.6</td>
<td>$535.00</td>
<td>$65.5K</td>
<td align="right">41</td>
<td align="right">42</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$23.0</td>
<td>$22.9</td>
<td>$22.9</td>
<td>$465.00</td>
<td>$64.1K</td>
<td align="right">115</td>
<td align="right">29</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$146.1</td>
<td>$146.1</td>
<td>$146.1</td>
<td>$400.00</td>
<td>$58.4K</td>
<td align="right">204</td>
<td align="right">4</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$14.1</td>
<td>$13.6</td>
<td>$13.74</td>
<td>$540.00</td>
<td>$56.3K</td>
<td align="right">139</td>
<td align="right">46</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Intuitive Surgical's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 975,331, the ISRG's price is down by -2.83%, now at $511.16. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 11 days.</li>
</ul>
<h3>What The Experts Say On Intuitive Surgical</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $550.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Evercore ISI Group persists with their In-Line rating on Intuitive Surgical, maintaining a target price of $550. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuitive Surgical with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

Intuitive Surgical Options Trading: A Deep Dive into Market Sentiment

Intuitive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food &amp; Drug Administration (FDA) has cleared its latest innovation in advanced energy instrumentation for use with its multiport da Vinci systems.
Vessel Sealer Curved is a fully wristed, advanced bipolar electrosurgical instrument designed to seal, cut, grasp, and dissect tissue. It is the first of Intuitive's advanced energy instruments to receive FDA clearance for the transection of lymphatic vessels.
Vessel Sealer Curved offers enhanced multifunctionality and precision via its slim, curved jaw designed to follow the natural contours of anatomy, helping improve visibility and control especially in tight spaces and around critical structures. The instrument's mechanical blade cuts closer to the tip, offering versatility as a dissector.
The FDA cleared Vessel Sealer Curved for grasping and blunt dissection of tissue, as well as bipolar coagulation and mechanical transection of blood vessels (veins and arteries) up to 7mm in diameter, lymphatic vessels, and tissue bundles that fit within the instrument's jaws. Vessel Sealer Curved is not indicated for tubal sterilization or tubal coagulation for sterilization procedures and should not be used for these procedures.

Intuitive Receives FDA Clearance For Its Vessel Sealer Curved, Advanced Bipolar Electrosurgical Instrument For Use With Multiport Da Vinci Systems

In the current market session, Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) stock price is at $533.92, after a 0.15% decrease. However, over the past month, the company's stock went up by 0.01%, and in the past year, by 19.09%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1751994031_0.png" alt="Past Year Chart" />

<h3>Intuitive Surgical P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 52.03 in the Health Care Equipment &amp; Supplies industry, Intuitive Surgical Inc. has a higher P/E ratio of 78.29. Shareholders might be inclined to think that Intuitive Surgical Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751994031_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: Intuitive Surgical

Evercore ISI Group analyst Vijay Kumar maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a In-Line and raises the price target from $470 to $550.

Evercore ISI Group Maintains In-Line on Intuitive Surgical, Raises Price Target to $550

Press Releases

General

U.S. FDA clears first stapler designed for single-port robotic surgery

New Research Explores Access to Minimally Invasive Care and the Impact of Robotic-Assisted Surgery

Intuitive Announces First Quarter Earnings

Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local  Excision/Resection

Intuitive Announces CEO Transition Effective July 1, 2025

30 years of Innovation and Impact: Dan Larson's Inspiring Story

Intuitive's da Vinci 5 Surgical System Receives CE Mark

Vessel Sealer Curved receives FDA clearance

Intuitive demonstrates telesurgery capabilities

Intuitive Announces Second Quarter Earnings

Abbott Laboratories

Baxter Intl

Becton, Dickinson and Company Common Stock

Becton Dickinson

Boston Scientific Corporation Common Stock

Boston Scientific

DexCom

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences

GE HealthCare Technologies Inc. - Common Stock

GE HealthCare Techs

Glaukos

Globus Medical, Inc. Class A Common Stock

Globus Medical

Hologic

IDEXX Laboratories

Inspire Medical Systems, Inc. Common Stock

Inspire Medical Systems

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies

Integer Holdings Corporation Common Stock

Integer Holdings

Masimo

Medtronic

Penumbra

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips

Insulet

ResMed

Smith & Nephew

Steris

Stryker

Teleflex

Zimmer Biomet Holdings, Inc. Common Stock

Zimmer Biomet Holdings

Piper Sandler

Truist Securities

RBC Capital

Wells Fargo

Untitled design - 2024-12-10T185819.364

Movers & Shakers

MBOT

Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics

Comments

Intuitive Surgical

Actualités

Dernières nouvelles pour Intuitive Surgical (NASDAQ:ISRG) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL